Cumulative mean fluorescent intensities of HLA specific antibodies predict antibody mediated rejections after kidney transplantation
暂无分享,去创建一个
A. Kribben | U. Eisenberger | H. Baba | F. Heinemann | O. Witzke | J. Becker | P. Horn | M. Lindemann | A. Heinold | D. Keles
[1] B. Banas,et al. Determination of unacceptable HLA antigen mismatches in kidney transplant recipients , 2021, HLA.
[2] S. Chadban,et al. Recommended Treatment for Antibody-mediated Rejection After Kidney Transplantation: The 2019 Expert Consensus From the Transplantion Society Working Group , 2019, Transplantation.
[3] G. Pantaleo,et al. Clinically-relevant threshold of preformed donor-specific anti-HLA antibodies in kidney transplantation. , 2016, Human immunology.
[4] J. Friedewald,et al. Assessing Antibody Strength: Comparison of MFI, C1q, and Titer Information , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[5] A. Konvalinka,et al. Utility of HLA Antibody Testing in Kidney Transplantation. , 2015, Journal of the American Society of Nephrology : JASN.
[6] A. Cabrita,et al. Analysis of preformed donor-specific anti-HLA antibodies characteristics for prediction of antibody-mediated rejection in kidney transplantation. , 2015, Transplant immunology.
[7] J. Scoazec,et al. Detection of C3d-binding donor-specific anti-HLA antibodies at diagnosis of humoral rejection predicts renal graft loss. , 2015, Journal of the American Society of Nephrology : JASN.
[8] V. Kosmoliaptsis,et al. Questioning the added value of Luminex single antigen beads to detect C1q binding donor HLA-specific antibodies. , 2014, Transplantation.
[9] S. Schaub,et al. Determinants of C1q Binding in the Single Antigen Bead Assay , 2014, Transplantation.
[10] D. Rush,et al. Banff 2013 Meeting Report: Inclusion of C4d‐Negative Antibody‐Mediated Rejection and Antibody‐Associated Arterial Lesions , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[11] J. Pascual,et al. Clinical relevance of pretransplant anti-HLA donor-specific antibodies: does C1q-fixation matter? , 2013, Transplant immunology.
[12] X. Jouven,et al. Complement-binding anti-HLA antibodies and kidney-allograft survival. , 2013, The New England journal of medicine.
[13] F. Christiansen,et al. Pre-transplant donor specific anti-HLA antibody is associated with antibody-mediated rejection, progressive graft dysfunction and patient death. , 2013, Transplant immunology.
[14] A. Webster,et al. Consensus Guidelines on the Testing and Clinical Management Issues Associated With HLA and Non-HLA Antibodies in Transplantation , 2013, Transplantation.
[15] Dominique Charron,et al. Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation. , 2010, Journal of the American Society of Nephrology : JASN.
[16] A. Kribben,et al. High negative predictive value of an amplified flow cytometry crossmatch before living donor kidney transplantation. , 2010, Human immunology.
[17] D. Rush,et al. Evidence for Antibody-Mediated Injury as a Major Determinant of Late Kidney Allograft Failure , 2010, Transplantation.
[18] Walter K. Kremers,et al. Baseline Donor‐Specific Antibody Levels and Outcomes in Positive Crossmatch Kidney Transplantation , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[19] E. Thervet,et al. Outcome of Subclinical Antibody‐Mediated Rejection in Kidney Transplant Recipients with Preformed Donor‐Specific Antibodies , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[20] F. Heinemann. HLA Genotyping and Antibody Characterization using the LuminexTM Multiplex Technology , 2009, Transfusion Medicine and Hemotherapy.
[21] J. Steiger,et al. Clinical Relevance of Pretransplant Donor-Specific HLA Antibodies Detected by Single-Antigen Flow-Beads , 2009, Transplantation.
[22] René J Duquesnoy,et al. Clinical usefulness of HLAMatchmaker in HLA epitope matching for organ transplantation. , 2008, Current opinion in immunology.
[23] A. Wiseman,et al. Detection of donor-specific antibodies using HLA-coated microspheres: another tool for kidney transplant risk stratification. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[24] P. Terasaki,et al. Significance of the positive crossmatch test in kidney transplantation. , 1969, The New England journal of medicine.
[25] P. Terasaki,et al. Microdroplet Assay of Human Serum Cytotoxins , 1964, Nature.
[26] G. Einecked,et al. Banff 07 Classification of Renal Allograft Pathology : Updates and Future Directions , 2008 .
[27] M. Bogman,et al. Banff classification for the histological diagnosis of renal graft rejection: what are the advantages? , 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.